Mass spectrometry-based screening identifies circulating immunoglobulinA–α1-microglobulin complex as potential biomarker in immunoglobulin A nephropathy

Boyang Xu,Li Zhu,Qingsong Wang,Yanfeng Zhao,Meng Jia,Sufang Shi,Lijun Liu,Jicheng Lv,Wenjia Lai,Jianguo Ji,Hong Zhang

DOI: https://doi.org/10.1093/ndt/gfaa352

IF: 7.1857

2020-12-22

Nephrology Dialysis Transplantation

Abstract:Abstract Background Immunoglobulin A nephropathy (IgAN) is characterized by predominant IgA deposition in the glomerular mesangium. Previous studies have proved that renal-deposited IgA in IgAN came from circulating IgA1-containing complexes (CICs). Methods To explore the composition of CICs in IgAN, we isolated CICs from IgAN patients and healthy controls and then quantitatively analyzed them by mass spectrometry. Meanwhile, the isolated CICs were used to treat human mesangial cells to monitor mesangial cell injury. Using the protein content and injury effects, the key constituent in CICs was identified. Then the circulating levels of identified key constituent–IgA complex were detected in an independent population by an in-house-developed enzyme-linked immunosorbent assay. Results By comparing the proteins of CICs between IgAN patients and controls, we found that 14 proteins showed significantly different levels. Among them, α1-microglobulin content in CICs was associated with not only in vitro mesangial cell proliferation and monocyte chemoattractant protein 1 secretion, but also in vivo estimated glomerular filtration rate (eGFR) levels and tubulointerstitial lesions in IgAN patients. Moreover, we found α1-microglobulin was prone to bind aberrant glycosylated IgA1. Additionally, elevated circulating IgA-α1-microglobulin complex levels were detected in an independent IgAN population and IgA-α1-microglobulin complex levels were correlated with hypertension, eGFR levels and Oxford T- scores in these IgAN patients. Conclusions Our results suggest that the IgA-α1-microglobulin complex is an important constituent in CICs and that circulating IgA-α1-microglobulin complex detection might serve as a potential noninvasive biomarker detection method for IgAN.

urology & nephrology,transplantation

What problem does this paper attempt to address?

The paper aims to address the components of circulating immune complexes (CICs) in IgA nephropathy (IgAN) and their role in the disease. Specifically, the study identifies the IgA-α1-microglobulin complex as a key component of CICs through mass spectrometry analysis and explores its relationship with the clinical and pathological features of IgAN patients. The study found that the IgA-α1-microglobulin complex is associated with mesangial cell proliferation and the secretion of inflammatory factors in vitro, as well as with patients' glomerular filtration rate (eGFR), hypertension, and tubulointerstitial injury in vivo. Additionally, the study developed an ELISA method to detect the levels of circulating IgA-α1-microglobulin complexes and validated its value as a potential non-invasive biomarker. Therefore, the main objective of this study is to identify the key components of CICs and evaluate their potential as diagnostic and prognostic indicators for IgAN.